Literature DB >> 17267261

Expression of functional human glutaminase in baculovirus system: affinity purification, kinetic and molecular characterization.

José A Campos-Sandoval1, Amada R López de la Oliva, Carolina Lobo, Juan A Segura, José M Matés, Francisco J Alonso, Javier Márquez.   

Abstract

Glutaminase catalyzes the hydrolysis of glutamine yielding stoichiometric amounts of glutamate plus ammonium ions. In mammals, there are two different genes encoding for glutaminase, known as liver (L) and kidney (K) types. The human L-type isoform expressed in baculovirus yielded functional recombinant enzyme in Sf9 insect cells. A novel affinity chromatography method, based on its specific interaction with a PDZ protein, was developed for purification. Kinetic constants were determined for the purified human isozyme, which showed an allosteric behaviour for glutamine, with a Hill index of 2.7 and S(0.5) values of 32 and 64 mM for high and low P(i) concentrations, respectively. Whereas the protein showed a low P(i) dependence typical for L-type glutaminases, the enzyme was unexpectedly inhibited by glutamate, a kinetic characteristic exclusive of K-type isozymes, and was slightly activated by ammonia, unlike the classical liver enzymes which show an absolute dependence on ammonia. Subcellular fractionation demonstrates that recombinant human glutaminase was targeted to both mitochondria and nucleus, and in both locations the protein was catalytically active. This is the first report of the expression of a functional L-type mammalian glutaminase enzyme. The study also provides a simple and efficient method for affinity purification of the recombinant enzyme. Moreover, the data imply that this human enzyme may represent a new isoform different from classical kidney and liver isozymes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17267261     DOI: 10.1016/j.biocel.2006.12.002

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  17 in total

1.  The origin and evolution of human glutaminases and their atypical C-terminal ankyrin repeats.

Authors:  Camila Cristina Pasquali; Zeyaul Islam; Douglas Adamoski; Igor Monteze Ferreira; Ricardo Diogo Righeto; Jefferson Bettini; Rodrigo Villares Portugal; Wyatt Wai-Yin Yue; Ana Gonzalez; Sandra Martha Gomes Dias; Andre Luis Berteli Ambrosio
Journal:  J Biol Chem       Date:  2017-05-19       Impact factor: 5.157

2.  Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function.

Authors:  Wenwei Hu; Cen Zhang; Rui Wu; Yvonne Sun; Arnold Levine; Zhaohui Feng
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-08       Impact factor: 11.205

3.  Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism.

Authors:  Alexandre Cassago; Amanda P S Ferreira; Igor M Ferreira; Camila Fornezari; Emerson R M Gomes; Kai Su Greene; Humberto M Pereira; Richard C Garratt; Sandra M G Dias; Andre L B Ambrosio
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-06       Impact factor: 11.205

Review 4.  A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis.

Authors:  William P Katt; Michael J Lukey; Richard A Cerione
Journal:  Future Med Chem       Date:  2017-01-23       Impact factor: 3.808

Review 5.  Metabolic changes during prostate cancer development and progression.

Authors:  Alicia-Marie K Beier; Martin Puhr; Matthias B Stope; Christian Thomas; Holger H H Erb
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-23       Impact factor: 4.322

6.  Active glutaminase C self-assembles into a supratetrameric oligomer that can be disrupted by an allosteric inhibitor.

Authors:  Amanda Petrina Scotá Ferreira; Alexandre Cassago; Kaliandra de Almeida Gonçalves; Marília Meira Dias; Douglas Adamoski; Carolline Fernanda Rodrigues Ascenção; Rodrigo Vargas Honorato; Juliana Ferreira de Oliveira; Igor Monteze Ferreira; Camila Fornezari; Jefferson Bettini; Paulo Sérgio Lopes Oliveira; Adriana Franco Paes Leme; Rodrigo Villares Portugal; Andre Luis Berteli Ambrosio; Sandra Martha Gomes Dias
Journal:  J Biol Chem       Date:  2013-08-08       Impact factor: 5.157

Review 7.  Targeting GLS1 to cancer therapy through glutamine metabolism.

Authors:  Wei Yu; XiangYu Yang; Qian Zhang; Li Sun; ShengTao Yuan; YongJie Xin
Journal:  Clin Transl Oncol       Date:  2021-05-23       Impact factor: 3.405

8.  Structure and activation mechanism of the human liver-type glutaminase GLS2.

Authors:  Igor M Ferreira; José Edwin N Quesñay; Alliny Cs Bastos; Camila T Rodrigues; Melanie Vollmar; Tobias Krojer; Claire Strain-Damerell; Nicola A Burgess-Brown; Frank von Delft; Wyatt W Yue; Sandra Mg Dias; Andre Lb Ambrosio
Journal:  Biochimie       Date:  2021-03-18       Impact factor: 4.079

9.  Mammalian glutaminase Gls2 gene encodes two functional alternative transcripts by a surrogate promoter usage mechanism.

Authors:  Mercedes Martín-Rufián; Marta Tosina; José A Campos-Sandoval; Elisa Manzanares; Carolina Lobo; J A Segura; Francisco J Alonso; José M Matés; Javier Márquez
Journal:  PLoS One       Date:  2012-06-05       Impact factor: 3.240

10.  p63 regulates glutaminase 2 expression.

Authors:  Arianna Giacobbe; Lucilla Bongiorno-Borbone; Francesca Bernassola; Alessandro Terrinoni; Elke Katrin Markert; Arnold J Levine; Zhaohui Feng; Massimilano Agostini; Lello Zolla; Alessandro Finazzi Agrò; Daniel A Notterman; Gerry Melino; Angelo Peschiaroli
Journal:  Cell Cycle       Date:  2013-04-10       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.